Evidence map›Paper›PMID 27696768›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2017

CD8+ T Cells Contribute to the Development of Coronary Arteritis in the Lactobacillus casei Cell Wall Extract-Induced Murine Model of Kawasaki Disease.

Magali Noval Rivas, Youngho Lee, Daiko Wakita, Norika Chiba, Jargalsaikhan Dagvadorj, Kenichi Shimada, Shuang Chen, Michael C Fishbein, Thomas J A Lehman, Timothy R Crother and 1 more

Open access · greenAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 72 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Gut Microbiota Alterations in Patients With Kawasaki Disease.Arteriosclerosis, thrombosis, and vascular biology · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Expansion of a Novel Subset of L-SelectinJournal of inflammation research · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Magali Noval RivasCedars-Sinai Medical Center, Los Angeles, California.
Youngho LeeCedars-Sinai Medical Center, Los Angeles, California.
Daiko WakitaCedars-Sinai Medical Center, Los Angeles, California.
Norika ChibaCedars-Sinai Medical Center, Los Angeles, California.
Jargalsaikhan DagvadorjCedars-Sinai Medical Center, Los Angeles, California.
Kenichi ShimadaCedars-Sinai Medical Center, Los Angeles, California.
Shuang ChenCedars-Sinai Medical Center, Los Angeles, California.
Michael C FishbeinUniversity of California, Los Angeles.
Thomas J A LehmanHospital for Special Surgery and Weill Medical College of Cornell University, New York, New York.
Timothy R CrotherCedars-Sinai Medical Center, Los Angeles, California.
Moshe ArditiCedars-Sinai Medical Center and University of California, Los Angeles.
Cedars-Sinai Medical Center · USUniversity of California, Los Angeles · USCornell University · US

Funding

Role of IL-1 in Bacterial ligand-induced vasculitis and myocarditisR01AI072726 · NIAID · CEDARS-SINAI MEDICAL CENTER · PI ARDITI, MOSHE · 2008 to 2020
$4.5M
Sequential release of IL-1alpha and IL-1beta leads to a two-hit model of acute lung injuryR01HL130353 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI SHIMADA, KENICHI · 2016 to 2020
$2.2M
Innate Immunity and Mouse Model of Kawasaki DiseaseK08AI070162 · NIAID · CEDARS-SINAI MEDICAL CENTER · PI SCHULTE, DANICA JENINE · 2007 to 2010
$508k
Potential Role of IL-1B Therapies for Treatment of Vasculitis of Kawasaki DiseaseR03AI097748 · NIAID · CEDARS-SINAI MEDICAL CENTER · PI ARDITI, MOSHE · 2012 to 2013
$167k
NHLBI NIH HHS R01 HL130353NIAID NIH HHS K08 AI070162NIAID NIH HHS R01 AI072726NIAID NIH HHS R03 AI097748
6 · The paper itself

Abstract

objectiveKawasaki disease (KD) is the leading cause of acquired heart disease among children in developed countries. Coronary lesions in KD in humans are characterized by an increased presence of infiltrating CD3+ T cells; however, the specific contributions of the different T cell subpopulations in coronary arteritis development remain unknown. Therefore, we sought to investigate the function of CD4+ and CD8+ T cells, Treg cells, and natural killer (NK) T cells in the pathogenesis of KD.

methodsWe addressed the function of T cell subsets in KD development by using a well-established murine model of Lactobacillus casei cell wall extract (LCWE)-induced KD vasculitis. We determined which T cell subsets were required for development of KD vasculitis by using several knockout murine strains and depleting monoclonal antibodies.

resultsLCWE-injected mice developed coronary lesions characterized by the presence of inflammatory cell infiltrates. Frequently, this chronic inflammation resulted in complete occlusion of the coronary arteries due to luminal myofibroblast proliferation (LMP) as well as the development of coronary arteritis and aortitis. We found that CD8+ T cells, but not CD4+ T cells, NK T cells, or Treg cells, were required for development of KD vasculitis.

conclusionThe LCWE-induced murine model of KD vasculitis mimics many histologic features of the disease in humans, such as the presence of CD8+ T cells and LMP in coronary artery lesions as well as epicardial coronary arteritis. Moreover, CD8+ T cells functionally contribute to the development of KD vasculitis in this murine model. Therapeutic strategies targeting infiltrating CD8+ T cells might be useful in the management of KD in humans.

Indexed as

Cell WallLacticaseibacillus caseiAnimalsArteritisCD8-Positive T-LymphocytesCell ExtractsCoronary Artery DiseaseDisease Models, AnimalMaleMice, Inbred C57BLMucocutaneous Lymph Node SyndromeCell Extracts

Identifiers

PMID27696768
PMCPMC5274597
OpenAlexW2528134306

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.